Essence Festival of Culture is taking responsibility for Lauryn Hill's performance ending after 3:30 a.m. on Saturday, July 5 ...

Hims & Hers Health reports 111% Q1 2025 revenue growth to $586M, driven by personalized treatments & strong margins. Read why ...

A woman was left horrified when she moved into a new home and the neighbour immediately started making demands about parking.

Lauryn Hills is off the hook as Essence takes blame for a set that wrapped after 3:30 a.m. Stephanie Mills, however, is still ...

If you suffered losses exceeding $50,000 in Hims between April 29, 2025 and June 23, 2025 and would like to discuss your ...

Hims & Hers’ stock price has swung wildly this year. The telehealth company’s public feud with drugmaker Novo Nordisk knocked off a nearly a third of its valuation on Monday. On Friday, Hims ...

A group of wel-wishers led by Peter Maina, founder of the Leaning Shoulder Compassionate Community Organisation built a new ...

Hims & Hers stands out for personalized, compounded medications and consistent margin expansion but faces rising risks tied to weight loss drugs. See why HIMS stock is a Hold.

Hims & Hers’ stock price has swung wildly this year. The price had at one point soared more than 150% this year before the Novo split knocked off a nearly a third of its valuation on Monday.

Hims & Hers Health is up 82.3% since the beginning of the year, but at $45.95 per share, it is still trading 33.2% below its 52-week high of $68.74 from February 2025. Investors who bought $1,000 ...

Up-and-coming telehealth company Hims & Hers Health (HIMS 1.22%) has capitalized on the weight loss drug craze to become one of the market's top performers over the past few years.

MNS leader Javed Shaikh's son Rahil has been booked for for outraging the modesty of a woman after he allegedly threatened ...